{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:29:11Z","timestamp":1787074151918,"version":"build-2736575974"},"reference-count":40,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"\n Background<\/jats:title>\n Accurate and up-to-date medicinal product information is essential for the safe and effective use of medicines. Electronic labeling (e-labeling) has emerged as a potential alternative to paper-based package inserts by enabling timely updates, improving accessibility, and supporting integration with digital health systems. However, regulatory approaches to pharmaceutical e-labeling remain fragmented across jurisdictions.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study examined how e-labeling policies have developed across International Coalition of Medicines Regulatory Authorities (ICMRA) member jurisdictions and explored the conditions associated with policies that position e-labeling as a replacement for paper-based product information.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a cross-sectional comparative policy analysis of publicly available national regulatory documents on pharmaceutical e-labeling issued between January 1, 2012, and May 31, 2026. The analysis focused on how regulatory intent, legal authority, implementation mechanisms, and replacement pathways were articulated in official policy documents across jurisdictions. A main corpus of official jurisdictional policy documents was supplemented by a triangulation corpus of international stakeholder documents. Hybrid thematic analysis and content analysis were used to identify and compare policy themes across jurisdictions. A 4-level e-labeling regulatory maturity framework was developed using 3 indicators: implementation status, level of authority, and expansion toward advanced considerations. Fuzzy-set qualitative comparative analysis (fsQCA) was then conducted across 19 jurisdictions to identify configurational patterns associated with paper-label replacement.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 81 policy documents from 20 jurisdictions were included in the main analysis, and 27 documents were included in the triangulation corpus. Nine themes were identified across 3 domains: e-labeling scope and implementation strategy, operational infrastructure, and advanced considerations. Most policies addressed target product information, medicine categories, transition approaches, interface mechanisms, and responsible entities. In contrast, structured digital formats, interoperability, and personalized information were less consistently addressed. The maturity assessment showed substantial variation across jurisdictions. Brazil and the Netherlands were classified at the highest maturity level, reflecting implementation with a legal basis and expansion toward advanced functions. The fsQCA identified 1 conservative sufficient configuration associated with paper-label replacement: digital infrastructure readiness, high e-labeling policy maturity, and explicit responsibility of the marketing authorization holder.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Pharmaceutical e-labeling has moved beyond early policy discussion in many ICMRA member jurisdictions, but regulatory maturity remains uneven. While most jurisdictions enable electronic access to product information, relatively few have established the legal and operational foundations to replace paper labeling. Paper-label replacement was associated with mature regulatory frameworks and clear operational responsibility. By combining a cross-jurisdictional regulatory maturity framework with fsQCA, this study provides a novel comparative approach that extends beyond previous descriptive studies by identifying the conditions associated with paper-label replacement. The proposed framework may offer a structured approach to assessing regulatory readiness and prioritizing the efforts required for effective legal development and implementation.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/96787","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:25:05Z","timestamp":1785914705000},"page":"e96787","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory Readiness for Paper Replacement in Global Pharmaceutical Electronic Labeling: Cross-Sectional Comparative Policy Analysis"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7348-3297","authenticated-orcid":false,"given":"Da Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5896-1645","authenticated-orcid":false,"given":"Ji Sun","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7087-7275","authenticated-orcid":false,"given":"Mari","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-3343","authenticated-orcid":false,"given":"In-Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1836-1707","authenticated-orcid":false,"given":"Jung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2196\/56591"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-022-00462-5"},{"issue":"4","key":"ref3","first-page":"3","volume":"19","author":"Lambot, N","year":"2022","journal-title":"Regulatory Rapporteur"},{"key":"ref4","unstructured":"EndangRE-labeling pilot project in IndonesiaAPAC e-Labeling Regulator\u2019s WorkshopApril 23, 2024Tokyo, Japan"},{"key":"ref5","unstructured":"LeeYE-labeling initiative and pilot project for pharmaceuticals in the Republic of KoreaMinistry of Food and Drug Safety20242026-07-06https:\/\/apac-asia.com\/images\/achievements\/pdf\/12th\/10_e-labeling5.E-labeling%20initiative%20and%20pilot%20project%20for%20pharmaceuticals%20in%20the%20Republic%20of%20Korea.pdf"},{"key":"ref6","year":"2020","journal-title":"Global Strategy on Digital Health 2020-2025"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3316\/qrj0902027"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijinfomgt.2021.102310"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"ref10","unstructured":"International Coalition of Medicines Regulatory Authorities (ICMRA)2026-07-06https:\/\/www.icmra.info\/drupal\/en"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z"},{"key":"ref12","author":"Braun, V","year":"2013","journal-title":"Successful Qualitative Research: A Practical Guide for Beginners"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00457"},{"key":"ref14","unstructured":"GSCF - e-labelling spotlight progressGlobal Self-Care Federation2026-07-01https:\/\/www.selfcarefederation.org\/resources\/gscf-e-labelling-spotlight-progress"},{"key":"ref15","unstructured":"Delivery information to consumers through e-labellingGlobal Self-Care Federation2026-07-01https:\/\/www.selfcarefederation.org\/resources\/delivery-information-consumers-through-e-labelling"},{"key":"ref16","unstructured":"Electronic product information (ePI): making the latest medicine\u2019s information available for patients without any delayEuropean Federation of Pharmaceutical Industries and Associations2026-07-01https:\/\/www.efpia.eu\/news-events\/the-efpia-view\/blog-articles\/electronic-product-information-epi-making-the-latest-medicine-s-information-available-for-patients -without-any-delay\/"},{"key":"ref17","unstructured":"Improving patient safety and health systems resilience through the use of electronic labelingInternational Federation of Pharmaceutical Manufacturers and Associations20232026-07-01https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/01\/i2023_IFPMA_Position-paper_Electronic-labeling.pdf"},{"key":"ref18","unstructured":"APAC e-labeling EWG position paper. Version 2.0. Asia Partnership Conference of Pharmaceutical AssociationsAPAC e-labeling EWG2026-06-30https:\/\/apac-asia.com\/images\/elabeling\/APAC_e-Labeling_PositionPaper_2026.pdf"},{"key":"ref19","unstructured":"United Nations Department of Economic and Social AffairsUN E-government survey 2024: e-government development indexUnited Nations Public Administration Network2026-06-23https:\/\/publicadministration.un.org\/egovkb\/en-us\/data-center"},{"key":"ref20","unstructured":"Electronic product information for human medicines in the European Union: key principlesEuropean Medicines Agency2026-06-23https:\/\/www.ema.europa.eu\/en\/electronic-product-information-human-medicines-european-union-key-principles"},{"key":"ref21","unstructured":"International Telecommunication UnionITU DataHub2026-06-23https:\/\/datahub.itu.int\/"},{"key":"ref22","unstructured":"StatisticsInternational Telecommunication Union20252026-06-29https:\/\/www.itu.int\/en\/ITU-D\/Statistics\/pages\/stat\/default.aspx"},{"key":"ref23","unstructured":"What constitutes human subjects research under Article 2(1) of the Enforcement Rule of the Bioethics and Safety Act?Seoul National University2026-08-12https:\/\/snurnd.snu.ac.kr\/?q=board\/bd013\/view\/2695"},{"key":"ref24","unstructured":"CMDh position paper on the use of mobile scanning and other technologies to be included in the labelling and\/or package leaflet in order to provide information about the medicinal productCo-ordination Group for Mutual recognition and Decentralised Procedures\u2014Human20262026-06-30https:\/\/www.paint-consult.com\/fileadmin\/editorial\/downloads\/guidelines_behoerden\/packungsbeilagen\/CMDh_313_2014_Rev8_12_2018_clean_Mobile_scanning_and_other_technologies.pdf"},{"key":"ref25","unstructured":"Mobile scanning and other technologies in the labelling and\/or package leaflet of centrally authorised medicinal productsEuropean Medicines Agency20262026-06-30https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/mobile-scanning-other-technologies-labelling-or-package-leaflet-centrally-authorised-medicinal-products_en.pdf"},{"key":"ref26","unstructured":"TrokicHE-labeling in 2026: key trends and global regulatory acceptanceGlobalVision20262026-06-30https:\/\/www.globalvision.co\/blog\/e-labeling-2026-key-trends-and-global-regulatory-acceptance"},{"key":"ref27","unstructured":"IntuitionLabs2025-07-06https:\/\/intuitionlabs.ai\/articles\/e-labeling-regulations-by-country"},{"key":"ref28","unstructured":"Administrative notice \u201cregarding applications for smartphones, etc. that allow users to browse the PMDA\u2019s website, which contains information on precautions, etc\"Pharmaceuticals and Medical Devices Agency2026-06-30https:\/\/www.pmda.go.jp\/files\/000240664.pdf"},{"key":"ref29","unstructured":"Assessment of main provisions and key EFPIA recommendations on the revision of the pharmaceutical packageEuropean Federation of Pharmaceutical Industries and Associations20232026-06-30https:\/\/www.efpia.eu\/media\/gy5j1nkt\/efpia-recommendations-on-the-revision-of-the-pharmaceutical-package.pdf"},{"key":"ref30","unstructured":"GSCF webinar: transitioning patient information leaflets from print to pixels \u2013 insights from South AfricaGlobal Self-Care Federation2026-06-30https:\/\/www.selfcarefederation.org\/news-events\/gscf-webinar-transitioning-patient-information-leaflets-print-pixels-insights-south"},{"key":"ref31","unstructured":"Reflection paper on linking to electronic product information (ePI) from EU medicine packagesEuropean Medicines Agency20252026-06-30https:\/\/www.ema.europa.eu\/en\/documents\/other\/draft-reflection-paper-linking-electronic-product-information-epi-eu-medicine-packages_en.pdf"},{"key":"ref32","unstructured":"European Medicines Regulatory Network (EMRN) electronic product information (ePI) implementation guideEuropean Medicines Regulatory Network2026-06-30https:\/\/epi.ema.europa.eu\/fhirig\/toc.html"},{"key":"ref33","unstructured":"Electronic product information (ePI) roadmapEuropean Medicines Agency20262026-06-30https:\/\/www.ema.europa.eu\/system\/files\/documents\/other\/electronic-product-information-epi-roadmap_en_0.pdf"},{"key":"ref34","unstructured":"Electronic product information: from principles to actionsAESGP, EFPIA, Medicines for Europe2026-06-30https:\/\/www.efpia.eu\/media\/589590\/electronic-product-information-from-principles-to-actions.pdf"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02413-z"},{"key":"ref36","unstructured":"Countries overview: spotlight on progress in the adoption of e-labelling for non-prescription medicinesGlobal Self-Care Federation20232026-06-30https:\/\/www.selfcarefederation.org\/resources\/countries-overview-spotlight-progress-adoption -e-labelling-non-prescription-medicines-0"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1109\/access.2021.3118960"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1109\/jsac.2020.3042421"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.22270\/ijdra.v13i2.766"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106605"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2026\/1\/e96787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:05:08Z","timestamp":1787072708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e96787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2196\/96787","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.96787","asserted-by":"object"}]},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}